Publications by authors named "Aathmika Kirubaharan"
Article Synopsis
- The study looked at 200 South Asian participants in Canada with existing cardiovascular disease to see how well the results of a previous study (REDUCE-IT) on a medication called icosapent ethyl (IPE) could apply to them.
- Findings showed that many of these high-risk, statin-treated South Asians are eligible for IPE, highlighting a significant need for tailored treatments within this demographic to help reduce their higher cardiovascular risks.
Background And Aim: The P2Y12 platelet receptor inhibitor ticagrelor is widely used in patients following acute coronary syndromes or in those who have received coronary stents. Bentracimab is a monoclonal antibody-based reversal agent that is being formally evaluated in a Phase 3 clinical trial. Here, we probe the knowledge, attitudes, and practice patterns of cardiac surgeons regarding their perioperative management of ticagrelor and potential application of a ticagrelor reversal agent.
View Article and Find Full Text PDF